AI
Tuesday, October 17, 2006 6:12:44 PM
Re: Value of cholesterol targets
Although this figure doesn't show it, you can actually plot the results of pivotal trials of lipid-lowering drugs (including, but not limited to statins) along the line.
The argument that is commonly advanced based on epidemiologic data is that there is no lower limit, down to about 30 mg/dL, at which lower isn't better.
I think Grundy is going to have something to say about this.
Now I'm going to read the article.
Although this figure doesn't show it, you can actually plot the results of pivotal trials of lipid-lowering drugs (including, but not limited to statins) along the line.
The argument that is commonly advanced based on epidemiologic data is that there is no lower limit, down to about 30 mg/dL, at which lower isn't better.
I think Grundy is going to have something to say about this.
Now I'm going to read the article.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
